Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Global Extremity Replacement Implants Market $3.1 Billion by 2029

The global market for extremity replacement implants anticipated to become $3.1 billion by 2029, growing steadily at a CAGR of 6.3% over the forecast period, driven by growing elderly population, increasing prevalence of bone and joint disorders such as osteoarthritis, osteoporosis, rheumatoid arthritis, as well as improvements in surgical and pain management techniques, and moderate incremental innovations.

  • The rising aging population and increasing prevalence of chronic diseases like obesity and arthritis continue to fuel the demand for better implants and new surgical techniques. These driving forces have also helped create more awareness in younger populations about the availability of joint replacement surgeries, and companies stepping up to meet the demand.
  • The need for faster recovery, lesser post-operative pain and cost-effective procedures is driving the demand for minimally invasive replacement implants.
    • The increased use of multi-modal pain control programs is playing a significant role in shifting extremity replacements to outpatient settings.
    • Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.
Global Extremity Replacement Implants

The global market for extremity replacement implants research report provides market size ($million 2021 to 2031), market volume (number of surgical procedures), market share analysis, growth trends and forecast (CAGR%, 2024 to 2031).

The global market for extremity replacement implants segmented by product [shoulder replacement implants (total shoulder arthroplasty, reverse shoulder arthroplasty, shoulder hemiarthroplasty, shoulder resurfacing, revision shoulder arthroplasty), elbow replacement implants, ankle replacement implants, small joint replacement implants], end user (hospitals, ambulatory surgical centers, orthopedic clinics), and geography.

  • Based on the products, the shoulder replacement implants segment accounted for the largest share of the total extremity replacement implants market, and also expected to grow at the fastest rate during the forecast period, owing to rising demand for better implants and new surgical techniques.
    • For example, in the emerging shoulder replacement segment, the advent of reverse shoulder arthroplasty is making shoulder replacement an option for an entirely new subset of patients, including younger people with sports-related injuries, creating more awareness among consumers, patients, and surgeons than ever are learning extremity replacement techniques.
      • The incremental innovation and technological advancements, new surgical techniques and greater awareness by consumers, patients, and surgeons that shoulder replacement and repair is an option for people of all ages, are all expected to drive significant growth in this segment over the coming years.
  • Shoulder resurfacing procedures have benefitted from significant improvements in implant technologies over the years. The new-generation implants have demonstrated improved clinical outcomes including reduced complication rates as well as reduced rates of revision due to implant loosening.
    • In the coming years, increasing awareness and the clinical benefits of stemless shoulders may help to increase shoulder arthroplasty volumes. The market for reverse shoulder arthroplasty is also being driven by the use of trabecular metal implants.
      • While challenges such as high revision rates and the need for training remain, the global market for shoulder arthroplasty implants is likely to continue growing at the fastest rate in the coming years.

The global market for extremity replacement implants research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the North America region dominated the total market for extremity replacement implant devices, followed by the Europe region.
    • The shoulder arthroplasty continues to be one of the fastest growing joint replacement procedures in the United States and Europe.
      • Significant improvements in implant technology and the subsequent commercial launch of implants are driving the market for arthroplasties in the US and Europe.
  • During the forecast period, the European and Asian markets are expected to see the fastest growth rate compared to the U.S. and the rest of the world markets.

In addition, the global market for extremity replacement devices report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major competitors operating in the global market for extremity implant devices and profiled in this report include Johnson & Johnson (DePuy Synthes), Smith & Nephew plc (Integra LifeSciences Holdings Corporation), Stryker Corporation, Wright Medical Group N.V. (Tornier, Inc.), and Zimmer Biomet.

  • Product
    • Shoulder Replacement Implants
      • Total Shoulder Arthroplasty (TSA)
      • Reverse Shoulder Arthroplasty
      • Shoulder Hemiarthroplasty
      • Shoulder Resurfacing
      • Revision Shoulder Arthroplasty
    • Elbow Replacement Implants
    • Ankle Replacement Implants
    • Small Joint Replacement Implants
  • End User
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Orthopedic Clinics
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Johnson & Johnson (DePuy Synthes)
    • Smith & Nephew plc (Integra LifeSciences Holdings Corporation)
    • Stryker Corporation
    • Wright Medical Group N.V. (Tornier, Inc.)
    • Zimmer Biomet

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com